Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | EMR | Common Stock | Award | +10.3K | +17.6% | 68.7K | Nov 6, 2023 | Direct | F1, F2, F3 | ||
transaction | EMR | Common Stock | Award | +13.6K | +19.87% | 82.3K | Nov 6, 2023 | Direct | F4, F5 | ||
holding | EMR | Common Stock | 543 | Nov 6, 2023 | 401(k) excess plan |
Id | Content |
---|---|
F1 | Acquisition of 10,276 shares pursuant to Rule 16b-3 upon payout of 18,684 earned units under a performance share award under a shareholder-approved benefit plan. The payout was based on the level of achievement of financial targets for the performance period ended September 30, 2023. Of these 18,684 units, 10,276 units were paid in shares of Issuer stock, with the remaining 8,408 units paid in cash to cover the reporting person's tax obligations. |
F2 | Price is not applicable to the acquisitions described in Note 1. |
F3 | Includes 569 shares acquired under Dividend Reinvestment Plans ("DRIPs"). |
F4 | Grant to Reporting Person of 13,641 restricted stock units under shareholder approved benefit plan pursuant to Rule 16b-3(d). |
F5 | Price is not applicable to acquisitions resulting from grants of restricted stock units. |